Novo Nordisk AS (NVO)
102.64
-2.63
(-2.50%)
USD |
NYSE |
Nov 21, 16:00
102.62
-0.02
(-0.02%)
After-Hours: 19:53
Novo Nordisk Market Cap: 456.05B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 467.74B |
| November 19, 2024 | 456.01B |
| November 18, 2024 | 443.48B |
| November 15, 2024 | 452.05B |
| November 14, 2024 | 468.01B |
| November 13, 2024 | 475.07B |
| November 12, 2024 | 475.74B |
| November 11, 2024 | 484.76B |
| November 08, 2024 | 476.36B |
| November 07, 2024 | 478.93B |
| November 06, 2024 | 468.83B |
| November 05, 2024 | 490.05B |
| November 04, 2024 | 488.23B |
| November 01, 2024 | 498.14B |
| October 31, 2024 | 498.19B |
| October 30, 2024 | 503.93B |
| October 29, 2024 | 498.32B |
| October 28, 2024 | 500.01B |
| October 25, 2024 | 504.55B |
| October 24, 2024 | 507.01B |
| October 23, 2024 | 515.11B |
| October 22, 2024 | 518.35B |
| October 21, 2024 | 522.18B |
| October 18, 2024 | 525.56B |
| October 17, 2024 | 526.14B |
| Date | Value |
|---|---|
| October 16, 2024 | 525.30B |
| October 15, 2024 | 524.32B |
| October 14, 2024 | 533.09B |
| October 11, 2024 | 534.24B |
| October 10, 2024 | 523.10B |
| October 09, 2024 | 520.74B |
| October 08, 2024 | 521.63B |
| October 07, 2024 | 524.17B |
| October 04, 2024 | 512.37B |
| October 03, 2024 | 512.22B |
| October 02, 2024 | 518.45B |
| October 01, 2024 | 525.26B |
| September 30, 2024 | 529.98B |
| September 27, 2024 | 537.50B |
| September 26, 2024 | 553.28B |
| September 25, 2024 | 565.08B |
| September 24, 2024 | 558.36B |
| September 23, 2024 | 550.61B |
| September 20, 2024 | 567.57B |
| September 19, 2024 | 600.41B |
| September 18, 2024 | 587.86B |
| September 17, 2024 | 587.59B |
| September 16, 2024 | 609.40B |
| September 13, 2024 | 609.85B |
| September 12, 2024 | 608.36B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
116.04B
Minimum
Mar 20 2020
654.30B
Maximum
Jun 25 2024
299.77B
Average
245.84B
Median
Market Cap Benchmarks
| Ascendis Pharma AS | 7.334B |
| Amgen Inc | 155.82B |
| AstraZeneca PLC | 199.21B |
| Grifols SA | 5.801B |
| Viking Therapeutics Inc | 5.757B |
Market Cap Related Metrics
| PE Ratio | 33.26 |
| PS Ratio | 11.65 |
| PEG Ratio | 1.182 |
| Price to Book Value | 25.26 |
| Price to Free Cash Flow | 46.66 |
| Price | 102.64 |
| Earnings Yield | 3.01% |
| PEGY Ratio | 1.127 |
| Operating PE Ratio | 26.61 |
| Normalized PE Ratio | 33.26 |